Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
ixekizumab
MeSH Supplementary Concept Data 2025
Details
Concepts
MeSH Supplementary
ixekizumab
Unique ID
C549079
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C549079
Entry Term(s)
LY-2439821
LY2439821
Taltz
Pharm Action
Dermatologic Agents
Registry Numbers
BTY153760O
Previous Indexing
*ANTIBODIES, MONOCLONAL (2010-2011)
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
451
Note
A humanized anti-interleukin 17 monoclonal antibody used for the treatment of
PSORIASIS
.
Source
Arthritis Rheum. 2010 Apr;62(4):929-39
Indexing Information
Interleukin-17
Date of Entry
2010/05/03
Revision Date
2021/02/12
Expand All
Collapse All
ixekizumab
Preferred
Concept UI
M0572546
Registry Numbers
BTY153760O
Terms
ixekizumab
Preferred Term
Term UI
T820548
Date
04/09/2012
LexicalTag
NON
ThesaurusID
LY2439821
Narrower
Concept UI
M0546166
Terms
LY2439821
Preferred Term
Term UI
T770664
Date
05/03/2010
LexicalTag
LAB
ThesaurusID
NLM (2010)
LY-2439821
Term UI
T000908849
Date
10/05/2016
LexicalTag
LAB
ThesaurusID
NLM (2017)
Taltz
Narrower
Concept UI
M000622270
Terms
Taltz
Preferred Term
Term UI
T000908449
Date
09/30/2016
LexicalTag
TRD
ThesaurusID
NLM (2017)
page delivered in 0.005s